Not every patient with multiple sclerosis should be treated at time of diagnosis

Arch Neurol. 2006 Apr;63(4):611-4. doi: 10.1001/archneur.63.4.611.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Clinical Protocols / standards*
  • Disability Evaluation
  • Disease Progression
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Interferon beta-1a
  • Interferon-beta / adverse effects
  • Interferon-beta / immunology
  • Magnetic Resonance Imaging / standards
  • Multiple Sclerosis / diagnosis*
  • Multiple Sclerosis / therapy*
  • Patient Selection*
  • Secondary Prevention
  • Time Factors
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Interferon-beta
  • Interferon beta-1a